Lobbying Filing Details

Total Spending

$980,000

Activities

4

Lobbyists

2

Gov't Entities

10

Filing Information
Filing UUID:
c70ae8ac-bf7a-4bef-a33d-b303be46f805
Type:
Q4 - 4th Quarter - Report
Period:
2025 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:
January 20, 2026 at 4:32 PM
Income:
$0
Expenses:
$980,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Christine Bloomquist
Registrant
ASTELLAS PHARMA US, INC.

Pharmaceuticals

Northbrook, Illinois
Client
ASTELLAS PHARMA US, INC.
Illinois, United States of America
Lobbying Activities (4)
Activity 1
Copyright/Patent/Trademark

Issues related to IP/Bayh-Dole Act (Pub.L. 96-517).

Foreign Entity Issues: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

Lobbyists (2)
  • JONATHAN OEHMEN
  • AKSHAI DATTA
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Health Issues

H.R. 1300/S. 297, PSA screening bills; Issues related to Women's Health and Menopause (no specific bills); Issues related to Eye Screening and Access (no specific bills); Issues related to implementation of the Inflation Reduction Act (Pub. L. 117-169); Issues Related to OBBA (Pub. L. No: 119-21); Issues related to health care transparency.

Foreign Entity Issues: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

Lobbyists (2)
  • JONATHAN OEHMEN
  • AKSHAI DATTA
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Centers For Medicare and Medicaid Services (CMS)
  • Natl Institutes of Health (NIH)
Activity 3
Medicare/Medicaid

Issues pertaining to Medicare Part D; H.R. 1300/S. 297 PSA screening bills; Issues related to the Inflation Reduction Act (Pub. L. 117-169); Issues related to OBBA (Pub. L. No: 119-21).

Foreign Entity Issues: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

Lobbyists (2)
  • JONATHAN OEHMEN
  • AKSHAI DATTA
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 4
Taxation/Internal Revenue Code

Issues related to OBBA (Pub. L. No: 119-21).

Foreign Entity Issues: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

Lobbyists (2)
  • JONATHAN OEHMEN
  • AKSHAI DATTA
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.